Lantern Pharma (LTRN) Q4 2025 Earnings

Nov 13Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.54
-0.49
-0.44
-0.39

Details

Expected EPS
-0.47
Actual EPS
-0.39
Surprise EPS
0.08
Surprise Percent
+17.02%

Description

⁨Lantern Pharma⁩ (⁦LTRN⁩) has reported earnings of ⁦-0.39⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts